These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


475 related items for PubMed ID: 26254549

  • 1. Transforming growth factor-β1 acts via TβR-I on microglia to protect against MPP(+)-induced dopaminergic neuronal loss.
    Liu Z, Chen HQ, Huang Y, Qiu YH, Peng YP.
    Brain Behav Immun; 2016 Jan; 51():131-143. PubMed ID: 26254549
    [Abstract] [Full Text] [Related]

  • 2. TGF-β1 Neuroprotection via Inhibition of Microglial Activation in a Rat Model of Parkinson's Disease.
    Chen X, Liu Z, Cao BB, Qiu YH, Peng YP.
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):433-446. PubMed ID: 28429275
    [Abstract] [Full Text] [Related]

  • 3. Treg Cells Protect Dopaminergic Neurons against MPP+ Neurotoxicity via CD47-SIRPA Interaction.
    Huang Y, Liu Z, Cao BB, Qiu YH, Peng YP.
    Cell Physiol Biochem; 2017 Sep; 41(3):1240-1254. PubMed ID: 28268219
    [Abstract] [Full Text] [Related]

  • 4. TGF-β1 protection against Aβ1-42-induced hippocampal neuronal inflammation and apoptosis by TβR-I.
    Fang XX, Sun GL, Zhou Y, Qiu YH, Peng YP.
    Neuroreport; 2018 Jan 17; 29(2):141-146. PubMed ID: 29200096
    [Abstract] [Full Text] [Related]

  • 5. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z, Qiu AW, Huang Y, Yang Y, Chen JN, Gu TT, Cao BB, Qiu YH, Peng YP.
    Brain Behav Immun; 2019 Oct 17; 81():630-645. PubMed ID: 31351185
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y, Zhang Q, Xi J, Xiao B, Li Y, Ma C.
    Int J Clin Exp Pathol; 2015 Oct 17; 8(3):2354-64. PubMed ID: 26045742
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity.
    Kim WK, Hwang SY, Oh ES, Piao HZ, Kim KW, Han IO.
    J Immunol; 2004 Jun 01; 172(11):7015-23. PubMed ID: 15153523
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
    Ramalingam M, Kim SJ.
    J Cell Biochem; 2016 Apr 01; 117(4):917-26. PubMed ID: 26364587
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TGFβ1 inhibits IFNγ-mediated microglia activation and protects mDA neurons from IFNγ-driven neurotoxicity.
    Zhou X, Zöller T, Krieglstein K, Spittau B.
    J Neurochem; 2015 Jul 01; 134(1):125-34. PubMed ID: 25827682
    [Abstract] [Full Text] [Related]

  • 14. Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.
    Qian L, Wei SJ, Zhang D, Hu X, Xu Z, Wilson B, El-Benna J, Hong JS, Flood PM.
    J Immunol; 2008 Jul 01; 181(1):660-8. PubMed ID: 18566433
    [Abstract] [Full Text] [Related]

  • 15. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
    Yan X, Liu DF, Zhang XY, Liu D, Xu SY, Chen GX, Huang BX, Ren WZ, Wang W, Fu SP, Liu JX.
    Int J Mol Sci; 2017 Feb 12; 18(2):. PubMed ID: 28208679
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways.
    Martin MM, Buckenberger JA, Jiang J, Malana GE, Knoell DL, Feldman DS, Elton TS.
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep 12; 293(3):L790-9. PubMed ID: 17601799
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y, Zeng Y, Meng T, Gao X, Huang B, He D, Ran X, Du J, Zhang Y, Fu S, Hu G.
    Int Immunopharmacol; 2019 Oct 12; 75():105739. PubMed ID: 31351366
    [Abstract] [Full Text] [Related]

  • 20. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
    Ghosh A, Langley MR, Harischandra DS, Neal ML, Jin H, Anantharam V, Joseph J, Brenza T, Narasimhan B, Kanthasamy A, Kalyanaraman B, Kanthasamy AG.
    J Neuroimmune Pharmacol; 2016 Jun 12; 11(2):259-78. PubMed ID: 26838361
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.